Literature DB >> 25982246

The role of primary tumor resection in neuroblastoma: When and how much?

Michael P La Quaglia1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25982246     DOI： 10.1002/pbc.25585

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  6 in total

1.  Radical Surgery Improves Survival in Patients with Stage 4 Neuroblastoma.

Authors:  Katherin Vollmer; Stefan Gfroerer; Till-Martin Theilen; Konrad Bochennek; Thomas Klingebiel; Udo Rolle; Henning Fiegel
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

Review 2.  Management of Neuroblastoma: ICMR Consensus Document.

Authors:  Deepak Bansal; Sidharth Totadri; Girish Chinnaswamy; Sandeep Agarwala; Tushar Vora; Brijesh Arora; Maya Prasad; Gauri Kapoor; Venkatraman Radhakrishnan; Siddharth Laskar; Tanvir Kaur; G K Rath; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2017-04-03       Impact factor: 1.967

3.  Advances in the treatment of pediatric solid tumors: A 50-year perspective.

Authors:  Michael P LaQuaglia; Justin T Gerstle
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

4.  Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.

Authors:  Janina Fischer; Alexandra Pohl; Ruth Volland; Barbara Hero; Martin Dübbers; Grigore Cernaianu; Frank Berthold; Dietrich von Schweinitz; Thorsten Simon
Journal:  BMC Cancer       Date:  2017-08-04       Impact factor: 4.430

5.  Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma.

Authors:  Sara A Mansfield; M Beth McCarville; John T Lucas; Matthew J Krasin; Sara M Federico; Victor M Santana; Wayne L Furman; Andrew M Davidoff
Journal:  Ann Surg Oncol       Date:  2021-07-02       Impact factor: 5.344

Review 6.  Advances in the Surgical Treatment of Neuroblastoma.

Authors:  Yan-Bing Luo; Xi-Chun Cui; Lin Yang; Da Zhang; Jia-Xiang Wang
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.